Maxim Group Thinks Yield10 Bioscience Inc’s Stock is Going to Recover


Maxim Group analyst James Jang initiated coverage with a Buy rating on Yield10 Bioscience Inc (NASDAQ: YTEN) today and set a price target of $7. The company’s shares closed yesterday at $1.40, close to its 52-week low of $1.35.

Jang observed:

“Yield10’s focus is to help reduce future food demand stress. Large opportunity for value creation in agriculture. YTEN’s gene editing technology represents a significant opportunity for the non-GMO agricultural sector. Research license with Monsanto should enable faster development and commercialization of YTEN’s gene traits.”

According to TipRanks.com, Jang is a 5-star analyst with an average return of 21.9% and a 54.1% success rate. Jang covers the Services sector, focusing on stocks such as Dynagas LNG Partners LP, Nordic American Tanker, and Eagle Bulk Shipping.

Currently, the analyst consensus on Yield10 Bioscience Inc is a Moderate Buy with an average price target of $7.

See today’s analyst top recommended stocks >>

The company has a one-year high of $8.67 and a one-year low of $1.35. Currently, Yield10 Bioscience Inc has an average volume of 253.2K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Yield10 Bioscience, Inc. is an agricultural bioscience company, which focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts